← Back to Search

Behavioral Intervention

Adapted CBT-I for Insomnia

N/A
Recruiting
Led By Wilfred R Pigeon, PhD
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months following the baseline assessment
Awards & highlights

Study Summary

This trial will test an adapted form of cognitive behavioral therapy for people with insomnia and hazardous alcohol use to see if it helps reduce these problems.

Who is the study for?
This trial is for adults in Monroe County, NY or nearby who drink more alcohol than low-risk guidelines suggest and have insomnia. They must speak English and not be getting treatment for alcohol issues, pregnant, planning pregnancy soon, or using IV drugs. People with serious medical conditions or significant sleep disorders other than insomnia are also excluded.Check my eligibility
What is being tested?
The study tests a new phone-delivered cognitive behavioral therapy (CBT) specifically designed for people who drink hazardously and have trouble sleeping. Participants will either receive this adapted CBT-I over four sessions or get education about sleep and alcohol as a control comparison.See study design
What are the potential side effects?
Since the interventions involve therapy and education without medications, there aren't typical side effects like you'd see with drugs. However, participants might experience discomfort discussing personal habits or feelings during sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months following the baseline assessment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months following the baseline assessment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Abstinence
Drinks per Drinking Day
Insomnia Severity

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Insomnia TreatmentExperimental Treatment1 Intervention
Cognitive-behavioral therapy for insomnia adapted to hazardous alcohol users comprised of four telephone-based sessions delivered over six weeks.
Group II: Education ControlPlacebo Group1 Intervention
A combination of alcohol education and sleep hygiene education comprised of four telephone-based sessions delivered over six weeks.

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor
840 Previous Clinical Trials
534,180 Total Patients Enrolled
7 Trials studying Insomnia
1,818 Patients Enrolled for Insomnia
Wilfred R Pigeon, PhDPrincipal InvestigatorUniversity of Rochester
1 Previous Clinical Trials
54 Total Patients Enrolled
1 Trials studying Insomnia
54 Patients Enrolled for Insomnia

Media Library

Insomnia Treatment (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05973955 — N/A
Insomnia Research Study Groups: Education Control, Insomnia Treatment
Insomnia Clinical Trial 2023: Insomnia Treatment Highlights & Side Effects. Trial Name: NCT05973955 — N/A
Insomnia Treatment (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05973955 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor actively seeking participants?

"This particular trial is not seeking enrollees at this time. It was initially posted on October 1st, 2023 and its information has been updated most recently on July 25th, 2023. Nonetheless, there are 159 other clinical trials that are actively recruiting patients currently."

Answered by AI

Could I be accepted for participation in this clinical research?

"This investigation necessitates that participants are between 25 and 64 years of age, suffer from insomnia, and is limited to a cohort size of 70 individuals."

Answered by AI

Does your research include participants above the age of fifty?

"According to the criteria for participation, potential patients must fall in the 25-64 age range. Nevertheless, 19 studies are available for minors and 115 can be accessed by folks over 65 years old."

Answered by AI
~47 spots leftby Mar 2026